PATIENT-REPORTED OUTCOMES (PRO) IN PATIENTS (PTS) WITH HER2− ADVANCED BREAST CANCER (ABC) RECEIVING TALAZOPARIB (TALA) VS PHYSICIAN’S CHOICE CHEMOTHERAPY (PCT): A FOCUS ON EMBRACA GERMLINE BRCA1 AND BRCA2 MUTATION (GBRCA1/2M) SUBGROUPS
Gonçalves, Anthony, Quek, Ruben G.W., Bhattacharyya, Helen, Ettl, Johannes, Hurvitz, Sara A., Rugo, Hope S.Volume:
48
Journal:
The Breast
DOI:
10.1016/s0960-9776(19)30743-x
Date:
November, 2019
Fichier:
PDF, 51 KB
2019
File converter
Plus de résultats de recherche
More benefits 
